Statistics for Enanta Pharmaceuticals (id:7880 ENTA)

Valuation metrics

Market cap

202.77M

Enterprise value

198.02M

Trailing P/E (ttm)

-1.46

Forward P/E

-1.99

PEG ratio

-1.99

Price/Sales (ttm)

2.82

Price/Book (mrq)

1.36

Enterprise Value/Revenue

2.75

Enterprise Value/EBITDA

-1.64

Overview

Shares outstanding

21.19M

Float

15.44M

Shares short

3.44M

% Held by insiders

0.06%

% Held by institutions

1.01%

Average volume (10 days)

108.37K

Average volume (90 days)

Price summary

52-Week low

8.51

52-Week high

17.80

52-Week change

-2.57%

Beta

0.57

50-Day moving average

11.36

200-Day moving average

13.10

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

September 30th, 2023

Most recent quarter (mrq)

June 30th, 2024

Profitability

Profit margin

-160.27%

Operating margin

-134.58%

Operational effectiveness

Return on assets

-17.18%

Return on equity

-59.64%

Income statement

Revenue (ttm)

3.41

Revenue per share (ttm)

3.41

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-120,341,000.00

Net income to common (ttm)

-115,329,000.00

Diluted EPS (ttm)

-5.45

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

230.08M

Total cash per share (mrq)

10.86

Total debt (mrq)

226.17M

Total Debt/Equity (mrq)

151.88

Current ratio (mrq)

492.20%

Book value per share (mrq)

7.03

Cash flow

Cash flow statement

-89,966,000.00

Levered free cash flow (LFCF)

-63,273,624.00